BCRX logo

BioCryst Pharmaceuticals (BCRX) Net Margin

Annual Net Margin

-68.36%
+22.89%+25.08%

31 December 2023

BCRX Net Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Margin

-11.99%
-0.40%-3.45%

30 September 2024

BCRX Quarterly Net Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BCRX Net Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+25.1%+71.2%
3 y3 years+93.3%+91.6%
5 y5 years+86.1%+99.4%

BCRX Net Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+93.3%-3.5%+91.9%
5 y5 yearsat high+93.3%-81.7%+99.4%
alltimeall time-279.1%+99.6%-126.6%+100.0%

BioCryst Pharmaceuticals Net Margin History

DateAnnualQuarterly
Sept 2024
-
-11.99%(+3.5%)
June 2024
-
-11.59%(-69.6%)
Mar 2024
-
-38.14%(-42.3%)
Dec 2023
-68.36%(-25.1%)
-66.09%(+58.6%)
Sept 2023
-
-41.67%(-54.4%)
June 2023
-
-91.31%(+17.8%)
Mar 2023
-
-77.54%(-13.8%)
Dec 2022
-91.25%(-22.1%)
-89.94%(+60.4%)
Sept 2022
-
-56.08%(-37.6%)
June 2022
-
-89.82%(-39.6%)
Mar 2022
-
-148.62%(+294.2%)
Dec 2021
-117.11%(-88.6%)
-37.70%(-73.7%)
Sept 2021
-
-143.44%(+65.9%)
June 2021
-
-86.47%(-74.4%)
Mar 2021
-
-337.29%(-77.6%)
Dec 2020
-1026.35%(+360.3%)
-1506.30%(+99.3%)
Sept 2020
-
-755.74%(-43.8%)
June 2020
-
-1344.72%(+72.5%)
Mar 2020
-
-779.58%(>+9900.0%)
Dec 2019
-222.99%(-54.5%)
-6.60%(-99.7%)
Sept 2019
-
-2117.86%(-18.5%)
June 2019
-
-2598.69%(+392.6%)
Mar 2019
-
-527.50%(-47.5%)
Dec 2018
-490.25%(+87.7%)
-1005.20%(-50.6%)
Sept 2018
-
-2035.56%(+1278.7%)
June 2018
-
-147.64%(-77.2%)
Mar 2018
-
-648.31%(+29.0%)
Dec 2017
-261.18%(+24.8%)
-502.39%(+190.8%)
Sept 2017
-
-172.76%(-68.3%)
June 2017
-
-544.89%(+261.6%)
Mar 2017
-
-150.67%(+200.6%)
Dec 2016
-209.25%(+134.7%)
-50.13%(-66.2%)
Sept 2016
-
-148.50%(-56.3%)
June 2016
-
-340.11%(-28.2%)
Mar 2016
-
-473.69%(+20.2%)
Dec 2015
-89.15%(-73.2%)
-394.07%(+196.1%)
Sept 2015
-
-133.08%(-801.5%)
June 2015
-
18.97%(-108.5%)
Mar 2015
-
-222.15%(+3.7%)
Dec 2014
-332.08%(+91.2%)
-214.32%(-20.5%)
Sept 2014
-
-269.64%(-73.0%)
June 2014
-
-999.25%(+240.9%)
Mar 2014
-
-293.15%(+470.6%)
Dec 2013
-173.72%(+16.9%)
-51.38%(-84.7%)
Sept 2013
-
-334.91%(-77.4%)
June 2013
-
-1482.58%(+1069.3%)
Mar 2013
-
-126.79%(-53.0%)
Dec 2012
-148.64%(-48.7%)
-269.52%(+60.1%)
Sept 2012
-
-168.37%(-42.3%)
June 2012
-
-291.59%(+488.8%)
Mar 2012
-
-49.52%(-80.4%)
Dec 2011
-289.92%(+434.2%)
-252.53%(-8.3%)
Sept 2011
-
-275.46%(-36.8%)
June 2011
-
-435.64%(+81.8%)
Mar 2011
-
-239.69%(+292.2%)
Dec 2010
-54.27%(+201.0%)
-61.11%(-32.5%)
Sept 2010
-
-90.53%(-32.4%)
June 2010
-
-133.84%(+1245.1%)
Mar 2010
-
-9.95%(-136.1%)
Dec 2009
-18.03%
27.60%(-127.4%)
DateAnnualQuarterly
Sept 2009
-
-100.75%(-44.5%)
June 2009
-
-181.41%(-14.9%)
Mar 2009
-
-213.17%(-824.8%)
Dec 2008
-43.73%(+7.2%)
29.41%(-129.1%)
Sept 2008
-
-101.14%(-78.8%)
June 2008
-
-477.96%(+292.9%)
Mar 2008
-
-121.64%(+1399.9%)
Dec 2007
-40.79%(-94.2%)
-8.11%(-84.9%)
Sept 2007
-
-53.68%(+3.6%)
June 2007
-
-51.79%(-46.2%)
Mar 2007
-
-96.35%(-79.9%)
Dec 2006
-702.16%(-95.9%)
-480.41%(-44.9%)
Sept 2006
-
-871.68%(+34.7%)
June 2006
-
-647.18%(-36.7%)
Mar 2006
-
-1022.31%(-97.0%)
Dec 2005
-17.19 K%(+174.3%)
-34.32 K%(+43.6%)
Sept 2005
-
-23.89 K%(+145.3%)
June 2005
-
-9737.93%(-29.3%)
Mar 2005
-
-13.77 K%(+363.1%)
Dec 2004
-6264.19%(+222.2%)
-2973.07%(-34.9%)
Sept 2004
-
-4565.52%(-61.2%)
June 2004
-
-11.76 K%(+665.9%)
Dec 2003
-1944.12%(+4250.2%)
-
Sept 2003
-
-1535.59%(+25.6%)
June 2003
-
-1222.56%(+35.1%)
Mar 2003
-
-905.19%(+9.2%)
Sept 2002
-
-828.88%(-20.4%)
Mar 2002
-
-1041.93%(+616.0%)
Dec 2001
-44.69%(-87.2%)
-145.53%(-1287.0%)
Sept 2001
-
12.26%(-53.5%)
June 2001
-
26.36%(-113.4%)
Mar 2001
-
-196.73%(-14.2%)
Dec 2000
-349.19%(+64.7%)
-229.20%(+78.4%)
Sept 2000
-
-128.44%(+14.3%)
June 2000
-
-112.41%(-91.5%)
Mar 2000
-
-1316.31%(-99.4%)
Dec 1999
-212.00%(+182.7%)
-
Sept 1999
-
-220.00 K%(>+9900.0%)
June 1999
-
-13.69%(-97.1%)
Mar 1999
-
-480.00%(+28.0%)
Dec 1998
-75.00%(-92.9%)
-375.00%(-933.3%)
Sept 1998
-
45.00%(-101.5%)
June 1998
-
-3000.00%(0.0%)
Mar 1998
-
-3000.00%(+20.0%)
Dec 1997
-1060.00%(+120.3%)
-
Sept 1997
-
-2500.00%(+1090.5%)
June 1997
-
-210.00%(-93.2%)
Mar 1997
-
-3100.00%(+272.0%)
Dec 1996
-481.25%(-88.8%)
-
Sept 1996
-
-833.33%(+1080.5%)
June 1996
-
-70.59%(-96.3%)
Mar 1996
-
-1900.00%(-13.6%)
Dec 1995
-4300.00%(+336.2%)
-2200.00%(+15.8%)
Sept 1995
-
-1900.00%(+18.8%)
June 1995
-
-1600.00%(+10.3%)
Mar 1995
-
-1450.00%(+61.1%)
Dec 1994
-985.71%
-900.00%(+12.5%)
Sept 1994
-
-800.00%(-57.9%)
June 1994
-
-1900.00%(+18.8%)
Mar 1994
-
-1600.00%

FAQ

  • What is BioCryst Pharmaceuticals annual net profit margin?
  • What is the all time high annual net margin for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual net margin year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly net profit margin?
  • What is the all time high quarterly net margin for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly net margin year-on-year change?

What is BioCryst Pharmaceuticals annual net profit margin?

The current annual net margin of BCRX is -68.36%

What is the all time high annual net margin for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual net profit margin is -18.03%

What is BioCryst Pharmaceuticals annual net margin year-on-year change?

Over the past year, BCRX annual net profit margin has changed by +22.89% (+25.08%)

What is BioCryst Pharmaceuticals quarterly net profit margin?

The current quarterly net margin of BCRX is -11.99%

What is the all time high quarterly net margin for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly net profit margin is 45.00%

What is BioCryst Pharmaceuticals quarterly net margin year-on-year change?

Over the past year, BCRX quarterly net profit margin has changed by +29.68% (+71.23%)